Abstract:P450 oxidoreductase (POR) is an electron-donating flavoprotein required for the activity of all microsomal cytochrome P450 enzymes. We sequenced 5,655 bp of the POR gene in a representative population of 842 healthy unrelated individuals in four ethnic groups: 218 African Americans, 260 Caucasian Americans, 179 Chinese Americans, and 185 Mexican Americans. One hundred forty SNPs were detected, of which 43 were found in >1% of alleles. Twelve SNPs were in the POR promoter region. Fifteen of 32 exonic variations… Show more
“…Our long-standing biochemical research into the mechanism of this critical flavoprotein (12) led us to explore the structure/ function relationships responsible for these phenotypes by expressing and purifying POR variants of interest reported in the literature (13)(14)(15)(16)(17)(18)(19)(20). The variant A287P was reported as the most common mutation found in the Caucasian population (10,14), and these studies were verified and extended to establish genotype-phenotype correlations in a cohort of patients from 11 countries (21).…”
Human NADPH-cytochrome P450 oxidoreductase (POR) gene mutations are associated with severe skeletal deformities and disordered steroidogenesis. The human POR mutation A287P presents with disordered sexual development and skeletal malformations. Difficult recombinant expression and purification of this POR mutant suggested that the protein was less stable than WT. The activities of cytochrome P450 17A1, 19A1, and 21A2, critical in steroidogenesis, were similar using our purified, full-length, unmodified A287P or WT POR, as were those of several xenobiotic-metabolizing cytochromes P450, indicating that the A287P protein is functionally competent in vitro, despite its functionally deficient phenotypic behavior in vivo. Differential scanning calorimetry and limited trypsinolysis studies revealed a relatively unstable A287P compared with WT protein, leading to the hypothesis that the syndrome observed in vivo results from altered POR protein stability. The crystal structures of the soluble domains of WT and A287P reveal only subtle differences between them, but these differences are consistent with the differential scanning calorimetry results as well as the differential susceptibility of A287P and WT observed with trypsinolysis. The relative in vivo stabilities of WT and A287P proteins were also examined in an osteoblast cell line by treatment with cycloheximide, a protein synthesis inhibitor, showing that the level of A287P protein post-inhibition is lower than WT and suggesting that A287P may be degraded at a higher rate. Current studies demonstrate that, unlike previously described mutations, A287P causes POR deficiency disorder due to conformational instability leading to proteolytic susceptibility in vivo, rather than through an inherent flavin-binding defect.
“…Our long-standing biochemical research into the mechanism of this critical flavoprotein (12) led us to explore the structure/ function relationships responsible for these phenotypes by expressing and purifying POR variants of interest reported in the literature (13)(14)(15)(16)(17)(18)(19)(20). The variant A287P was reported as the most common mutation found in the Caucasian population (10,14), and these studies were verified and extended to establish genotype-phenotype correlations in a cohort of patients from 11 countries (21).…”
Human NADPH-cytochrome P450 oxidoreductase (POR) gene mutations are associated with severe skeletal deformities and disordered steroidogenesis. The human POR mutation A287P presents with disordered sexual development and skeletal malformations. Difficult recombinant expression and purification of this POR mutant suggested that the protein was less stable than WT. The activities of cytochrome P450 17A1, 19A1, and 21A2, critical in steroidogenesis, were similar using our purified, full-length, unmodified A287P or WT POR, as were those of several xenobiotic-metabolizing cytochromes P450, indicating that the A287P protein is functionally competent in vitro, despite its functionally deficient phenotypic behavior in vivo. Differential scanning calorimetry and limited trypsinolysis studies revealed a relatively unstable A287P compared with WT protein, leading to the hypothesis that the syndrome observed in vivo results from altered POR protein stability. The crystal structures of the soluble domains of WT and A287P reveal only subtle differences between them, but these differences are consistent with the differential scanning calorimetry results as well as the differential susceptibility of A287P and WT observed with trypsinolysis. The relative in vivo stabilities of WT and A287P proteins were also examined in an osteoblast cell line by treatment with cycloheximide, a protein synthesis inhibitor, showing that the level of A287P protein post-inhibition is lower than WT and suggesting that A287P may be degraded at a higher rate. Current studies demonstrate that, unlike previously described mutations, A287P causes POR deficiency disorder due to conformational instability leading to proteolytic susceptibility in vivo, rather than through an inherent flavin-binding defect.
“…Thus, the contribution of common POR variants to variability of tacrolimus metabolism is of great interest. POR*28, the most common sequence variant in POR gene, induces an amino acid substitution (C>T, p.Ala503Val) and influence the electron binding moiety of POR [23] . A previous in vitro study showed that this mutation could decrease CYP3A4 activity.…”
Aim: Cytochrome P450 oxidoreductase (POR) is the only flavoprotein that donates electrons to all microsomal P450 enzymes (CYP), and several POR SNPs have been shown to be important contributors to altered CYP activity or CYP-mediated drug metabolism. In this study we examined the association between 6 POR SNPs and tacrolimus concentrations in Chinese renal transplant recipients. Methods: A total of 154 renal transplant recipients were enrolled. Genotyping of CYP3A5*3 and 6 POR SNPs was performed. All patients received a triple immunosuppressive regimen comprising tacrolimus, mycophenolate mofetil and prednisone. Dose-adjusted tacrolimus trough concentrations were obtained on d 7 (C 0D7 /D) after transplantation when steady-state concentration of tacrolimus was achieved (dosage had been unchanged for more than 3 d).Results: Tacrolimus C 0D7 /D in CYP3A5*3/*3/ POR rs1057868-rs2868177 GC-GT diplotype carriers was 1.62-and 2.72-fold higher than those in CYP3A5*3/*3/ POR rs1057868-rs2868177 GC-GT diplotype non-carriers and CYP3A5*1 carriers (220.17±48.09 vs 135.69±6.86 and 80.84±5.27 ng/mL/mg/kg, respectively, P<0.0001). Of CYP3A5*3/*3/ POR rs1057868-rs2868177GC-GT diplotype carriers, 85.71% exceeded the upper limit of the target range (8 ng/mL), which was also significantly higher compared with the latter two groups (14.29% and 0.00%, respectively, P<0.0001). The CYP3A5*3 and POR rs1057868-rs2868177 GC-GT diplotype explained 31.7% and 5.7%, respectively, of the inter-individual variability of tacrolimus C 0D7 /D, whereas the POR rs1057868-rs2868177 GC-GT diplotype could explain 10.9% of the inter-individual variability of tacrolimus C 0D7 /D in CYP3A5 non-expressers. Conclusion: The CYP3A5*3 and POR rs1057868-rs2868177 GC-GT diplotype accounted for the inter-individual variation of tacrolimus C 0D7 /D. Genotyping of POR rs1057868-rs2868177 diplotypes would help to differentiate initial tacrolimus dose requirements and to achieve early target C 0 ranges in Chinese renal transplant recipients.
“…P450 oxidoreductase complex operates as follows ( Figure 11): electrons from reduced NADPH (released as NADP+), are taken up by the FAD moiety, which is reduced to FADH 2 . Then FADH 2 reduces FMN to FMNH 2 , which in turn passes its two electrons to the CYP heme group, which is associated with the P450 oxidoreductase by electrostatic interactions (Huang et al, 2008). This electron transfer becomes a current of electron that P450 oxidoreductase must supply in the presence of high substrate concentrations.…”
Section: Redox Partners and Electron Transport Systemmentioning
confidence: 99%
“…Adapted from (Miller, W.L., 2005). Reprinted with permission from Huang et al, 2008. Copyright (2008 National Academy of Sciences, U.S.A. Figure 12) are electron transport hemeproteins which, similarly to cytochrome P450, are built around a central heme group.…”
Section: Redox Partners and Electron Transport Systemmentioning
confidence: 99%
“…11. Relationship of P450 oxidoreductase to a microsomal cytochrome P450 enzyme (Huang et al, 2008). ER is the endoplasmic reticulum and CYTO is the cytoplasm.…”
Section: Redox Partners and Electron Transport Systemmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.